Table 2 Cavity characteristics of the study cohort.
From: Significance of changes in cavity after treatment in Mycobacterium avium complex pulmonary disease
Cavity characteristics | Total (N = 136) | Microbiological cure (n = 74) | No cure (n = 62) | P-value | |
|---|---|---|---|---|---|
Baseline | Size, mm (IQR) | 25.8 (16.1–42.0) | 24.1 (16.4–42.1) | 26.2 (16.0–41.0) | 0.751 |
Thickness, mm (IQR) | 6.8 (3.8–9.4) | 6.2 (3.8–9.3) | 7.0 (3.8–10.7) | 0.471 | |
Number of cavities (IQR) | 1 (1–3) | 1 (1–3) | 2 (1–4) | 0.319 | |
Number of lobes infiltrated, (IQR) | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.461 | |
Bilaterality, n (%) | 25 (18.4) | 13 (17.6) | 12 (19.4) | 0.964 | |
Treatment completion | Size, mm (IQR) (n = 77) | 24.4 (17.6–47.7) | 21.8 (14.8–33.6) | 27.7 (18.6–49.8) | 0.155 |
Thickness, mm (IQR) (n = 77) | 5.7 (3.4–9.5) | 4.5 (3.4–9.5) | 6.1 (2.9–9.2) | 0.500 | |
Number of cavities (IQR) | 1 (0–3) | 1 (0–2) | 1 (1–3) | 0.064 | |
Number of lobes infiltrated, (IQR) | 1 (0–1) | 1 (0–1) | 1 (1–2) | 0.048 | |
Bilaterality, n (%) | 21 (15.4) | 10 (13.5) | 11 (17.7) | 0.659 | |
Obliteration, n (%) | 58 (42.6) | 40 (54.1) | 18 (29.0) | 0.006 | |
